Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Study calls for mass screening of Lynch Syndrome

This article was originally published in Clinica

Executive Summary

A US study has recommended that colon cancer patients should be tested for Lynch Syndrome, a hereditary condition which carries an extremely high risk for cancer. The study, published in the New England Journal of Medicine (May 5), showed that at least 23 out of 1,066 patients (2.2%) with recently-diagnosed adenocarcinoma of the colorectum and who underwent DNA microsatellite-instability testing and immunochemistry staining were found to have a Lynch Syndrome-associated deleterious mutation.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT055095

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel